Combined effects of fibrinogen genetic variability on atherosclerosis in patients with or without stable angina pectoris: Focus on the coagulation cascade and endothelial function

International Journal of Cardiology

Volumn 168, Issue 5, 2013, Pages 4602-4607

  Papageorgiou, Nikolaos ^a   Tousoulis, Dimitris ^a   Miliou, Antigoni ^a   Hatzis, George ^a   Kozanitou, Maria ^a   Androulakis, Emmanuel ^a   Charakida, Marietta ^a   Antonopoulos, Alexios ^a   Antoniades, Charalambos ^a   Briasoulis, Alexandros ^a   Giolis, Anastasios ^a   Bouras, George ^a   Pallantza, Zoi ^a   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Atherosclerosis; Coagulation; Coronary artery disease; Fibrinogen; Genetic polymorphisms

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; D DIMER; FIBRINOGEN; GENOMIC DNA; RESTRICTION ENDONUCLEASE;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD CLOTTING; BLOOD VESSEL PARAMETERS; BRACHIAL ARTERY; CAUCASIAN; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; ENDOTHELIAL DYSFUNCTION; FLOW MEDIATED DILATATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; STABLE ANGINA PECTORIS; THROMBOSIS;

ATHEROSCLEROSIS; COAGULATION; CORONARY ARTERY DISEASE; FIBRINOGEN; GENETIC POLYMORPHISMS;

ANGINA, STABLE; ATHEROSCLEROSIS; BLOOD COAGULATION; BRACHIAL ARTERY; DISEASE PROGRESSION; DNA; ENDOTHELIUM, VASCULAR; FEMALE; FIBRINOGEN; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; ULTRASONOGRAPHY, DOPPLER, PULSED; VASODILATION;

EID: 84886419014     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.07.162     Document Type: Article

References (29)

1. D. Tousoulis, A.M. Kampoli, and N. Papageorgiou Pathophysiology of atherosclerosis: the role of inflammation Curr Pharm Des 17 2011 4089 4110
2. L.F. Brass Thrombin and platelet activation Chest 124 3 Suppl. 2003 18S 25S
3. A. Briasoulis, D. Tousoulis, E.S. Androulakis, N. Papageorgiou, G. Latsios, and C. Stefanadis Endothelial dysfunction and atherosclerosis: focus on novel therapeutic approaches Recent Pat Cardiovasc Drug Discov 7 2012 21 32
4. A.M. Kampoli, D. Tousoulis, and N. Papageorgiou Clinical utility of biomarkers in premature atherosclerosis Curr Med Chem 19 2012 2521 2533
5. Y. Shi, Y. Wu, C. Bian, W. Zhang, J. Yang, and G. Xu Predictive value of plasma fibrinogen levels in patients admitted for acute coronary syndrome Tex Heart Inst J 37 2010 178 183
6. W.B. Kannel, R.B. D'Agostino, P.W. Wilson, A.J. Belanger, and D.R. Gagnon Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience Am Heart J 120 1990 672 676
7. D. Tousoulis, N. Papageorgiou, E. Androulakis, A. Briasoulis, C. Antoniades, and C. Stefanadis Fibrinogen and cardiovascular disease: genetics and biomarkers Blood Rev 25 2011 239 245
8. M.N. Mannila, P. Eriksson, C.G. Ericsson, A. Hamsten, and A. Silveira Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor XIII genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction Thromb Haemost 95 2006 420 427
9. M.N. Mannila, P. Eriksson, and P. Lundman Contribution of haplotypes across the fibrinogen gene cluster to variation in risk of myocardial infarction Thromb Haemost 93 2005 570 577
10. I. Kardys, A.G. Uitterlinden, A. Hofman, J.C.M. Witteman, and M.P.M. de Maat Fibrinogen gene haplotypes in relation to risk of coronary events and coronary and extracoronary atherosclerosis: the Rotterdam Study Thromb Haemost 97 2007 288 295
11. F.M. van 't Hooft, S.J. von Bahr, A. Silveira, A. Iliadou, P. Eriksson, and A. Hamsten Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration Arterioscler Thromb Vasc Biol 19 1999 3063 3070
12. G. Mancia, G. De Backer, and A. Dominiczak 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur Heart J 28 2007 1462 1536
13. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Circulation 106 2002 3143 3421
14. American Diabetes Association Standards of Medical Care in Diabetes-2010 Diabetes Care 33 2010 S11 S61
15. G. Siasos, D. Tousoulis, and C. Vlachopoulos Short-term treatment with L-arginine prevents the smoking-induced impairment of endothelial function and vascular elastic properties in young individuals Int J Cardiol 126 2008 394 399
16. D. Tousoulis, C. Antoniades, and C. Stefanadis Evaluating endothelial function in humans: a guide to invasive and non-invasive techniques Heart 91 2005 553 558
17. S. Rodriguez, T.R. Gaunt, and I.N. Day Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies Am J Epidemiol 169 4 2009 Feb 15 505 514
18. N. Papageorgiou, D. Tousoulis, G. Siasos, and C. Stefanadis Is fibrinogen a marker of inflammation in coronary artery disease? Hellenic J Cardiol 51 2010 1 9
19. L. Wilhelmsen, K. Svärdsudd, K. Korsan-Bengtsen, B. Larsson, L. Welin, and G. Tibblin Fibrinogen as a risk factor for stroke and myocardial infarction N Engl J Med 311 1984 501 505
20. W.B. Kannel, P.A. Wolf, W.P. Castelli, and R.B. D'Agostino Fibrinogen and risk of cardiovascular disease. The Framingham Study JAMA 258 1987 1183 1186
21. A.M. Carter, M.W. Mansfield, M.H. Stickland, and P.J. Grant Beta-fibrinogen gene-455 G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM Diabetes Care 19 1996 1265 1268
22. M.N. Mannila, R.S. Lovely, and S.C. Kazmierczak Elevated plasma fibrinogen gamma' concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors J Thromb Haemost 5 2007 766 773
23. A.J. Sun, H.L. Ma, and X.Y. Chen Association of fibrinogen and fibrinogen gene beta148 and beta854 polymorphisms with coronary heart disease Cardiology 111 2008 167 170
24. X. Chen, M. Xu, L. Jin, J. Chen, and W. Chen Association of beta-fibrinogen gene -148C/T and -455G/A polymorphisms and coronary artery disease in Chinese population: a meta-analysis Sci China C Life Sci 51 2008 814 820
25. A. Tybjaerg-Hansen, B. Agerholm-Larsen, S.E. Humphries, S. Abildgaard, P. Schnohr, and B.G. Nordestgaard A common mutation (G-455- > A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study J Clin Invest 99 1997 3034 3039
26. F. Green, A. Hamsten, M. Blombäck, and S. Humphries The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden Thromb Haemost 70 1993 915 920
27. C.L. Carty, P. Heagerty, and S.R. Heckbert Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study Ann Hum Genet 74 2010 1 10
28. M.P. Sie, A. Isaacs, and M.P. de Maat Genetic variation in the fibrinogen-alpha and fibrinogen-gamma genes in relation to arterial stiffness: the Rotterdam study J Hypertens 27 2009 1392 1398
29. M. Menegatti, R. Asselta, and S. Duga Identification of four novel polymorphisms in the alpha and gamma fibrinogen genes and analysis of association with plasma levels of the protein Thromb Res 103 2001 299 307